407 related articles for article (PubMed ID: 36258033)
1. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.
Huang DQ; Mathurin P; Cortez-Pinto H; Loomba R
Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):37-49. PubMed ID: 36258033
[TBL] [Abstract][Full Text] [Related]
2. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
3. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
Huang DQ; Tan DJH; Ng CH; Amangurbanova M; Sutter N; Lin Tay PW; Lim WH; Yong JN; Tang A; Syn N; Muthiah MD; Tan EXX; Dave S; Tay B; Majzoub AM; Gerberi D; Kim BK; Loomba R
Clin Gastroenterol Hepatol; 2023 May; 21(5):1169-1177. PubMed ID: 35940513
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
Abe H; Aida Y; Seki N; Sugita T; Tomita Y; Nagano T; Itagaki M; Sutoh S; Nagatsuma K; Itoh K; Matsuura T; Aizawa Y
J Gastroenterol Hepatol; 2015 Sep; 30(9):1376-83. PubMed ID: 25778454
[TBL] [Abstract][Full Text] [Related]
6. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers.
Stickel F; Lutz P; Buch S; Nischalke HD; Silva I; Rausch V; Fischer J; Weiss KH; Gotthardt D; Rosendahl J; Marot A; Elamly M; Krawczyk M; Casper M; Lammert F; Buckley TWM; McQuillin A; Spengler U; Eyer F; Vogel A; Marhenke S; von Felden J; Wege H; Sharma R; Atkinson S; Franke A; Nehring S; Moser V; Schafmayer C; Spahr L; Lackner C; Stauber RE; Canbay A; Link A; Valenti L; Grove JI; Aithal GP; Marquardt JU; Fateen W; Zopf S; Dufour JF; Trebicka J; Datz C; Deltenre P; Mueller S; Berg T; Hampe J; Morgan MY
Hepatology; 2020 Jul; 72(1):88-102. PubMed ID: 31630428
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
9. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
Huang DQ; El-Serag HB; Loomba R
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):223-238. PubMed ID: 33349658
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Fattovich G; Stroffolini T; Zagni I; Donato F
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
[TBL] [Abstract][Full Text] [Related]
11. Global epidemiology of cirrhosis - aetiology, trends and predictions.
Huang DQ; Terrault NA; Tacke F; Gluud LL; Arrese M; Bugianesi E; Loomba R
Nat Rev Gastroenterol Hepatol; 2023 Jun; 20(6):388-398. PubMed ID: 36977794
[TBL] [Abstract][Full Text] [Related]
12. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
[TBL] [Abstract][Full Text] [Related]
13. Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis.
Rodríguez-Escaja C; Á Navascués C; González-Diéguez L; Cadahía V; Varela M; de Jorge MÁ; Castaño-García A; Rodríguez M
Rev Esp Enferm Dig; 2021 Jul; 113(7):505-511. PubMed ID: 33244982
[TBL] [Abstract][Full Text] [Related]
14. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.
Vaz J; Eriksson B; Strömberg U; Buchebner D; Midlöv P
BMC Gastroenterol; 2020 Apr; 20(1):84. PubMed ID: 32245414
[TBL] [Abstract][Full Text] [Related]
15. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
[TBL] [Abstract][Full Text] [Related]
16. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
[TBL] [Abstract][Full Text] [Related]
17. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study.
Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
Scand J Gastroenterol; 2019 Aug; 54(8):1027-1032. PubMed ID: 31389730
[No Abstract] [Full Text] [Related]
18. Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.
Pais R; Lebray P; Rousseau G; Charlotte F; Esselma G; Savier E; Thabut D; Rudler M; Eyraud D; Vezinet C; Siksik JM; Vaillant JC; Hannoun L; Poynard T; Ratziu V
Clin Gastroenterol Hepatol; 2015 May; 13(5):992-9.e2. PubMed ID: 25459558
[TBL] [Abstract][Full Text] [Related]
19. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]